Xiangyu MedicalLtd Future Growth
Future criteria checks 5/6
Xiangyu MedicalLtd is forecast to grow earnings and revenue by 37.1% and 25.3% per annum respectively. EPS is expected to grow by 36.8% per annum. Return on equity is forecast to be 13.9% in 3 years.
Key information
37.1%
Earnings growth rate
36.8%
EPS growth rate
| Medical Equipment earnings growth | 26.5% |
| Revenue growth rate | 25.3% |
| Future return on equity | 13.9% |
| Analyst coverage | Low |
| Last updated | 06 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,330 | 395 | 307 | 447 | 3 |
| 12/31/2025 | 1,104 | 325 | -84 | 393 | 3 |
| 12/31/2024 | 896 | 263 | -193 | 302 | 3 |
| 9/30/2024 | 710 | 121 | -295 | 152 | N/A |
| 6/30/2024 | 748 | 176 | -335 | 160 | N/A |
| 3/31/2024 | 771 | 228 | -302 | 209 | N/A |
| 12/31/2023 | 745 | 227 | -251 | 228 | N/A |
| 9/30/2023 | 674 | 212 | -201 | 267 | N/A |
| 6/30/2023 | 602 | 193 | -89 | 269 | N/A |
| 3/31/2023 | 547 | 154 | -19 | 247 | N/A |
| 12/31/2022 | 489 | 125 | -16 | 187 | N/A |
| 9/30/2022 | 529 | 163 | -23 | 184 | N/A |
| 6/30/2022 | 528 | 156 | -42 | 148 | N/A |
| 3/31/2022 | 508 | 177 | -21 | 137 | N/A |
| 12/31/2021 | 523 | 202 | 32 | 166 | N/A |
| 9/30/2021 | 533 | 212 | 34 | 199 | N/A |
| 6/30/2021 | 526 | 205 | 46 | 189 | N/A |
| 3/31/2021 | 531 | 210 | 107 | 246 | N/A |
| 12/31/2020 | 496 | 196 | 77 | 216 | N/A |
| 12/31/2019 | 427 | 129 | 135 | 156 | N/A |
| 12/31/2018 | 359 | 80 | 67 | 74 | N/A |
| 12/31/2017 | 289 | 64 | N/A | 59 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688626's forecast earnings growth (37.1% per year) is above the savings rate (2.8%).
Earnings vs Market: 688626's earnings (37.1% per year) are forecast to grow faster than the CN market (26.2% per year).
High Growth Earnings: 688626's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688626's revenue (25.3% per year) is forecast to grow faster than the CN market (13.9% per year).
High Growth Revenue: 688626's revenue (25.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688626's Return on Equity is forecast to be low in 3 years time (13.9%).